SC 13G/A | 2024-02-14 | LYTTON LAURENCE W | ALIMERA SCIENCES INC | 2,185,364 | 4.2% | EDGAR |
SC 13G/A | 2024-02-13 | Stonepine Capital Management, LLC | ALIMERA SCIENCES INC | 5,373,732 | 10.0% | EDGAR |
SC 13G/A | 2024-02-13 | HBM Healthcare Investments (Cayman) Ltd. | ALIMERA SCIENCES INC | 466,666 | 0.9% | EDGAR |
SC 13G/A | 2024-02-13 | BOOTHBAY FUND MANAGEMENT, LLC | ALIMERA SCIENCES INC | 3,198,708 | 6.1% | EDGAR |
SC 13G/A | 2024-02-13 | Altium Capital Management LP | ALIMERA SCIENCES INC | 2,660,000 | 5.0% | EDGAR |
SC 13G/A | 2023-12-08 | MORGAN STANLEY | ALIMERA SCIENCES INC | 916,246 | 1.8% | EDGAR |
SC 13G | 2023-08-23 | Altium Capital Management LP | ALIMERA SCIENCES INC | 2,984,803 | 5.7% | EDGAR |
SC 13D/A | 2023-08-16 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 9,429,808 | 18.0% | EDGAR |
SC 13G | 2023-08-14 | LYTTON LAURENCE W | ALIMERA SCIENCES INC | 2,984,803 | 5.7% | EDGAR |
SC 13G | 2023-08-10 | Stonepine Capital Management, LLC | ALIMERA SCIENCES INC | 5,377,711 | 10.0% | EDGAR |
SC 13G | 2023-08-10 | BOOTHBAY FUND MANAGEMENT, LLC | ALIMERA SCIENCES INC | 4,784,480 | 9.0% | EDGAR |
SC 13D/A | 2023-08-03 | Caligan Partners LP | ALIMERA SCIENCES INC | 17,635,154 | 33.1% | EDGAR |
SC 13D/A | 2023-08-03 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 9,429,808 | 18.0% | EDGAR |
SC 13D/A | 2023-05-19 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 1,659,654 | 18.8% | EDGAR |
SC 13D/A | 2023-05-18 | Caligan Partners LP | ALIMERA SCIENCES INC | 915,057 | 10.0% | EDGAR |
SC 13G/A | 2023-04-03 | Palo Alto Investors LP | ALIMERA SCIENCES INC | 0 | 0.0% | EDGAR |
SC 13D | 2023-03-31 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 748,838 | 10.0% | EDGAR |
SC 13D/A | 2023-03-28 | Caligan Partners LP | ALIMERA SCIENCES INC | 724,716 | 10.0% | EDGAR |
SC 13G/A | 2023-02-14 | Palo Alto Investors LP | ALIMERA SCIENCES INC | 802,423 | 11.4% | EDGAR |
SC 13G/A | 2023-02-08 | MORGAN STANLEY | ALIMERA SCIENCES INC | 666,246 | 9.5% | EDGAR |